Hypercalcemia
Hypercalcemia refers to an abnormal increase in serum ionized calcium concentration. When the amount of calcium entering the extracellular fluid (intestines, bones) exceeds the amount of calcium excreted (intestines, kidneys), hypercalcemia occurs, and the blood calcium concentration is higher than 2.75mmol/L. There are two major causes of hypercalcemia: PTH-dependent and PTH-independent hypercalcemia. It is generally believed that when serum calcium is above 3.75mmol/L, hypercalcemic crisis may occur, which is life-threatening if not properly handled and is a clinical emergency.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Primary hyperparathyroidism is often... -
Related symptoms:
Fatigue stupor headache depression fatigue -
Concurrent disease:
Related Drugs
Clodronate Disodium Capsules
Indication: 1. Hypercalcemia complicated by malignant tumors. 2. Bone pain caused by osteolytic cancer metastasis. 3. Can prevent or delay osteolytic bone metastasis of malignant tumors. 4. Various types of osteoporosis.
Manufacturer:
Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical Co., Ltd.
Ibandronate Sodium Injection
Indication: This product is suitable for hypercalcemia caused by malignant tumors with or without bone metastasis; it is used to treat bone pain caused by osteolytic bone metastasis of malignant tumors.
Manufacturer:
Nanjing Hencer Pharmaceutical Co., Ltd.
Ibandronic acid injection
Indication: Pathological (abnormal) increase in blood calcium (hypercalcemia) caused by a tumor.
CINACALCET- cinacalcet_tablet, film coated
Indication: Cinacalcet is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. 1 Limitations of Use: Hypercalcemia in adult patients with Parathyroid Carcinoma (PC). 2 Severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy. 3 Cinacalcet tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis [see Clinical Studies (14. 1) Cinacalcet tablets are not indicated for use in patients with CKD who are not on dialysis because of an increased risk of hypocalcemia [see Warnings and Precautions (5. 1) Cinacalcet tablets are indicated for the treatment of hypercalcemia in adult patients with Parathyroid Carcinoma [see Clinical Studies (14. 2) Cinacalcet tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy [see Clinical Studies (14.
Manufacturer:
AvKARE
CINACALCET_- cinacalcet_tablet, film coated
Indication: Cinacalcet is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. 1) Limitations of Use: Hypercalcemia in adult patients with Parathyroid Carcinoma (PC). 2) Severe hypercalcemia in adult patients with primary HPT who are unable to parathyroidectomy. 3) Cinacalcet tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis [see Clinical Studies (14. Limitations of Use: Cinacalcet tablets are not indicated for use in patients with CKD who are not on dialysis because of an increased risk of hypocalcemia [see Warnings and Precautions (5. 1)] Cinacalcet tablets are indicated for the treatment of hypercalcemia in adult patients with Parathyroid Carcinoma [see Clinical Studies (14. Cinacalcet tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy [see Clinical Studies (14.
Manufacturer:
Strides Pharma Inc.
Related Ingredients
-
Clodronate disodium Salt list
22560-50-5 -
Ibandronate sodium list
138844-81-2